-
FEATURED CONTENT
First lady Jill Biden has tested positive for COVID-19 and is currently experiencing "mild symptoms," in today's bite-sized hospital and health industry news from the District of Columbia, Illinois, and Kentucky.
- District of Columbia: The White House on Monday reported that first lady Jill Biden tested positive for COVID-19 and is currently experiencing "mild symptoms." According to CNN, the first lady had planned to begin teaching classes at Northern Virginia Community College before her diagnosis, but is now working with the school to find a substitute. President Joe Biden tested negative for COVID-19, and an administration official said there are currently no changes to the president's schedule. According to White House press secretary Karine Jean-Pierre, anyone who meets with President Biden is tested for COVID-19 beforehand. "We have testing protocols when – anytime somebody meets with the president," Jean-Pierre said. "So, I can tell you that anybody who meets with the president does indeed get tested. I do. We all do." (Mallonee/Judd, CNN, 9/5)
- Illinois: Walgreens last week announced that Rosalind Brewer stepped down as the company's CEO and left its board of directors. Ginger Graham, Walgreens' lead independent director, will serve as interim CEO. Brewer will advise the company as it searches for a permanent CEO and will receive a $375,000 monthly consulting fee through February 2024. In a statement, Walgreens executive chair Stefano Pessina thanked Brewer for her work, including helping the company navigate through the pandemic. According to Modern Healthcare, Brewer's departure is the latest leadership change at Walgreens after CFO James Kehoe left to join financial technology company FIS Global last month. "This change adds to the leadership turnover," said Lisa Gill, managing director of equity research at J.P. Morgan. "With [Walgreens] still in the midst of its healthcare-centric transformation, we view continued leadership uncertainty as adding to investor concerns." (Hudson, Modern Healthcare, 9/1)
- Kentucky: Humana last week filed a lawsuit in the U.S. District Court for the Northern District of Texas to prevent CMS from implementing a plan to collect overpayments to Medicare Advantage (MA) programs. The plan, which was announced in January, will collect overpayments dating to 2018, strengthen risk-adjustment data validation audits, and remove an adjustment factor designed to align MA with Medicare fee-for-service costs. According to CMS, the rule could lead to an estimated $4.7 billion in overpayments to be reclaimed from 2023 to 2032. However, Humana's lawsuit argues that CMS violated the Administrative Procedure Act of 1946, and the company has asked for an injunction to block the regulation. "The final rule will alter the Medicare Advantage program's actuarial foundations, with unpredictable consequences for Medicare Advantage organizations and the millions of seniors who rely on the Medicare Advantage program for their healthcare," Humana said. (Tepper, Modern Healthcare, 9/1)
Don't miss out on the latest Advisory Board insights
Create your free account to access 1 resource, including the latest research and webinars.
Want access without creating an account?
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
